文献速递艾滋病与性传播感染

早期抗逆转录病毒治疗的围产期HIV-1感染婴儿的肠道完整性生物标志物

Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
PubMed 文献 · J Infect Dis · 2018-01-01

比较56例接受早期抗逆转录病毒治疗的HIV-1阳性非洲婴儿与53例HIV-1暴露未感染(HEU)对照的肠道完整性生物标志物。3月龄时两组iFABP和 zonulin 水平无差异,但HIV阳性婴儿 zonulin 从3月龄至5月龄升高,5月龄时显著高于HEU婴儿,尽管病毒被抑制。

要点

  • 3月龄时HIV阳性与HEU婴儿的iFABP和zonulin水平无差异。
  • HIV阳性婴儿zonulin从3月龄至5月龄升高,5月龄时显著高于HEU婴儿。
  • 母乳喂养的婴儿iFABP水平 substantially 较低。

核心结论

  • 尽管早期抗逆转录病毒治疗实现病毒抑制,围产期HIV-1感染婴儿的zonulin水平从3月龄至5月龄升高,5月龄时显著高于HEU婴儿,提示肠道完整性标志物谱在围产期HIV-1感染中具有意义。

研究设计与样本

  • 比较56例接受早期抗逆转录病毒治疗的HIV-1阳性非洲婴儿与53例HIV-1暴露未感染(HEU)对照的肠道完整性生物标志物(iFABP和zonulin)。

主要发现

  • 3月龄时HIV阳性婴儿的iFABP和zonulin水平与HEU婴儿无差异,且 largely 与炎症和免疫激活生物标志物不相关。
  • HIV阳性婴儿zonulin水平从3月龄至5月龄升高,5月龄时显著高于HEU婴儿,尽管抗逆转录病毒治疗实现病毒抑制。
  • 母乳喂养的婴儿iFABP水平 substantially 较低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intestinal fatty acid binding protein (iFABP) levels did not differ between human immunodeficiency virus type 1 (HIV-1)- infected infants and uninfected infants exposed to HIV-1, but those who breastfed had substantially lower levels. Zonulin levels increased from 3 to 5.3 months of age with perinatal acquisition of HIV-1 despite early antiretroviral treatment. Biomarkers of intestinal integrity (ie, iFABP and zonulin) were compared in 56 HIV-1-positive African infants who received early antiretroviral treatment and 53 HIV-1-exposed but uninfected (HEU) controls. Despite heightened inflammation and immune activation in HIV-positive infants, iFABP and zonulin levels at 3 months of age were not different from those in HEU infants and largely were not correlated with inflammatory and immune activation biomarkers. However, zonulin levels increased and became significantly higher in HIV-positive infants as compared to HEU infants by 5 months of age, despite viral suppression due to antiretroviral treatment. These findings have implications for intestinal integrity biomarker profiling in perinatal HIV-1 infection.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Koay WLA, Lindsey JC, Uprety P, et al. Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants. J Infect Dis. 2018. PMID: 29762690. doi:10.1093/infdis/jiy271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。